Stay updated on Safety of Tarlatamab in Adults With SCLC Clinical Trial
Sign up to get notified when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.

Latest updates to the Safety of Tarlatamab in Adults With SCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new revision entry, v3.6.5, is added to the record history, replacing the previous v3.6.4. This indicates a software release update to the page rather than changes to trial data or content.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe footer revision label updated from v3.6.3 to v3.6.4. This reflects a new build of the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check53 days agoChange DetectedThe footer revision updated from v3.6.2 to v3.6.3. This represents a minor site/template update and does not alter page content.SummaryDifference0.0%

- Check60 days agoChange DetectedA new release entry, Revision: v3.6.2, has been added to the study record history and the older Revision: v3.6.0 entry has been removed. This updates the documented software version reflected on the page.SummaryDifference0.0%

- Check74 days agoChange DetectedRecruitment status updated to no longer look for participants, indicating enrollment has closed. The history also shows a new revision (v3.6.0) to the record, following the previous v3.5.5.SummaryDifference0.2%

- Check81 days agoChange DetectedA new revision entry, v3.5.5, was added to the history, replacing the prior v3.5.4.SummaryDifference0.0%

Stay in the know with updates to Safety of Tarlatamab in Adults With SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.